SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-014290
Filing Date
2002-04-09
Accepted
2002-04-09 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2076187zsc13g.txt SC 13G 8964
  Complete submission text file 0000912057-02-014290.txt   10942
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Subject) CIK: 0000904973 (see all company filings)

IRS No.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: SC 13G | Act: 34 | File No.: 005-44314 | Film No.: 02605875
SIC: 2836 Biological Products, (No Diagnostic Substances)